Protective effects of berberine in an experimental rat osteoarthritis model
about
AMPK activation--protean potential for boosting healthspan.Luteolin Inhibits the Activity, Secretion and Gene Expression of MMP-3 in Cultured Articular Chondrocytes and Production of MMP-3 in the Rat KneeSanmiao formula inhibits chondrocyte apoptosis and cartilage matrix degradation in a rat model of osteoarthritisStem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold?Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo.Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytesTrichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease.Treatment with SiMiaoFang, an anti-arthritis chinese herbal formula, inhibits cartilage matrix degradation in osteoarthritis rat modelBerberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signallingInsights into the Action Mechanisms of Traditional Chinese Medicine in Osteoarthritis.AMPK deficiency in chondrocytes accelerated the progression of instability-induced and ageing-associated osteoarthritis in adult mice.Berberis Vulgaris and Berberine: An Update Review.Inhibiting roles of berberine in gut movement of rodents are related to activation of the endogenous opioid system.Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling.
P2860
Q33689169-A97E927F-E4DE-45C8-8F2F-C609F3516BCCQ33765076-45A6EDE2-D4BD-4D0C-A70E-206B3DDC367CQ34119782-B87EBE0B-6F86-4BF2-BD72-04C1FF03E3BBQ34253770-8CD7C1D6-5B4E-4245-87A5-95C82757FC2CQ36015710-F6D357E8-0C01-401F-83B4-3C8EE67AF755Q37107226-EB5ABF41-1022-4D59-9A0B-C4DF36108097Q37190855-25E65F89-D928-47A8-8019-0575B8DBD3F7Q37244895-F69F09A0-110A-4021-9416-DEEDE26B45A1Q37595305-8B866D08-8699-4303-B86E-A290CFBE43CEQ37624893-8F9F79F9-A27C-44F3-B302-402ED3107842Q37657974-B3F57D7C-676E-438D-BCC8-F1C848F5161AQ38928488-EA6FEE78-CBC9-47C9-AF19-49EE88F28CD4Q44337636-B714DA98-4F2A-46B8-B3A2-4B25E77FA30EQ50599085-E7EA8213-1E1B-4266-85DA-19A7E2AAEA73Q54258642-BCB2A9B0-F6DE-4C12-A2D3-79222303DCE8
P2860
Protective effects of berberine in an experimental rat osteoarthritis model
description
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/06/01)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/06/01)
@nl
наукова стаття, опублікована в червні 2011
@uk
مقالة علمية (نشرت في يونيو 2011)
@ar
name
Protective effects of berberine in an experimental rat osteoarthritis model
@ast
Protective effects of berberine in an experimental rat osteoarthritis model
@en
Protective effects of berberine in an experimental rat osteoarthritis model
@nl
type
label
Protective effects of berberine in an experimental rat osteoarthritis model
@ast
Protective effects of berberine in an experimental rat osteoarthritis model
@en
Protective effects of berberine in an experimental rat osteoarthritis model
@nl
prefLabel
Protective effects of berberine in an experimental rat osteoarthritis model
@ast
Protective effects of berberine in an experimental rat osteoarthritis model
@en
Protective effects of berberine in an experimental rat osteoarthritis model
@nl
P2093
P2860
P3181
P356
P1476
Protective effects of berberine in an experimental rat osteoarthritis model
@en
P2093
Jia-peng Bao
Jing-li Tang
Li-dong Wu
Peng-fei Hu
Wei-ping Chen
P2860
P304
P3181
P356
10.1002/PTR.3359
P577
2011-06-01T00:00:00Z